Three senior level management officials of GlaxoSmithKline are now in China to prepare a response to the allegations of bribery and corruption in the country.

According to a person familiar with the matter, Chief Executive Andrew Witty has sent Abbas Hussain, GSK President Emerging Markets as well as the group's global head of internal audit and a senior legal official to China for controlling the crisis. The tree officials are cooperating with the authorities in China to investigate the scandal that has dented the company’s reputation and has raised doubts over its internal systems.

Police in China had accused GSK of bribing officials and doctors on Monday for increasing sales and the prices of medicines in the Chinese markets. IT has been alleged that the company paid up to 3 billion yuan or $489 million to 700 travel agencies and consultancies for facilitating the transfer of bribes.

Britain's biggest drug-maker has shown that it is taking the situation seriously by sending top three officials to the country, which is an important and fast growing market for the industry. GSK also said that it is concerned over the allegations against it operations in China.